Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Turek

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Carcinogenesis|November 23, 2014
Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integrationMichael J Lace, James R Anson, Thomas H Haugen, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 13, 2000
p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancerK F Summersgill, E M Smith, H L Kirchner, et al.
Journal of Virology|August 30, 2008
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytesMichael J Lace, James R Anson, Gregory S Thomas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neckDonghong Wang, Justine M Ritchie, Elaine M Smith, et al.
Virology|May 5, 2009
Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformationThomas H Haugen, Michael J Lace, Takaoki Ishiji, et al.
Infectious Diseases in Obstetrics and Gynecology|March 3, 2005
HPV prevalence and concordance in the cervix and oral cavity of pregnant womenE M Smith, J M Ritchie, J Yankowitz, et al.
The Pediatric Infectious Disease Journal|August 28, 2007
Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescentsElaine M Smith, Sandhya Swarnavel, Justine M Ritchie, et al.
International Journal of Cancer|October 31, 2009
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancerElaine M Smith, Michael Pawlita, Linda M Rubenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1994
Direct vesicoureteral scintigraphy: quantifying early outcome predictors in children with primary refluxP D Mozley, S Heyman, J W Duckett, et al.
The Journal of General Virology|June 26, 2009
Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation siteMichael J Lace, Yasushi Yamakawa, Masato Ushikai, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Carcinogenesis|November 23, 2014
Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integrationMichael J Lace, James R Anson, Thomas H Haugen, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 13, 2000
p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancerK F Summersgill, E M Smith, H L Kirchner, et al.
Journal of Virology|August 30, 2008
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytesMichael J Lace, James R Anson, Gregory S Thomas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neckDonghong Wang, Justine M Ritchie, Elaine M Smith, et al.
Virology|May 5, 2009
Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformationThomas H Haugen, Michael J Lace, Takaoki Ishiji, et al.
Infectious Diseases in Obstetrics and Gynecology|March 3, 2005
HPV prevalence and concordance in the cervix and oral cavity of pregnant womenE M Smith, J M Ritchie, J Yankowitz, et al.
The Pediatric Infectious Disease Journal|August 28, 2007
Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescentsElaine M Smith, Sandhya Swarnavel, Justine M Ritchie, et al.
International Journal of Cancer|October 31, 2009
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancerElaine M Smith, Michael Pawlita, Linda M Rubenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1994
Direct vesicoureteral scintigraphy: quantifying early outcome predictors in children with primary refluxP D Mozley, S Heyman, J W Duckett, et al.
The Journal of General Virology|June 26, 2009
Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation siteMichael J Lace, Yasushi Yamakawa, Masato Ushikai, et al.
Pageof 9